Oric Pharmaceuticals
ORIC
12.01
+0.03
+0.25%
Oric Pharmaceuticals
US · ORIC
#3089 by market cap
Listed 2020
12.01
+0.03
+0.25%
Live - 5344 symbols - heartbeat 214s ago
· 2026-10-08 07:33
Pre-market
12.01
0.00%
After-hours
12.01
0.00%
- Market cap
- 1.24B
- P/E (TTM)i
- -9.24
- P/Bi
- 3.27
- EPSi
- -1.47
- Div yieldi
- 0.00%
- 52W posi
- 64%
Reader sentiment
Are you bullish or bearish on ORIC?
Anonymous reader poll. Unscientific, not investment advice.
About Oric Pharmaceuticals
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
- Founded
- 2014
- CEO
- Mr. Jacob M. Chacko, M.B.A.,M.D.
- Employees
- 104
- Headquarters
- South San Francisco, California, United States of America
- Fiscal year end
- 12-31
- Website
- oricpharma.com
Company profile
- Exchange
- US
- Symbol
- ORIC
- Market-cap rank
- #3089
- Listing date
- 2020-04-24
- Market cap
- 1.24B
- Float cap
- 1.07B
- Shares out
- 103.65M
- Float shares
- 88.69M
Sectors & themes
Biotechnology
Quote time 2026-10-08 07:33:13 · For reference only, not investment advice and not tailored to your situation.